[Title 21 CFR 1308.02]
[Code of Federal Regulations (annual edition) - April 1, 1996 Edition]
[Title 21 - FOOD AND DRUGS]
[Chapter II - DRUG ENFORCEMENT]
[Part 1308 - SCHEDULES OF CONTROLLED SUBSTANCES]
[Sec. 1308.02 - Definitions.]
[From the U.S. Government Publishing Office]




  21
  FOOD AND DRUGS
  9
  1996-04-01
  1996-04-01
  false
  
  1308.02
  Sec. 1308.02
  
    FOOD AND DRUGS
    DRUG ENFORCEMENT
    SCHEDULES OF CONTROLLED SUBSTANCES
  


Sec. 1308.02   Definitions.

    As used in this part, the following terms shall have the meanings 
specified:
    (a) The term Act means the Controlled Substance Act (84 Stat. 1242; 
21 U.S.C. 801) and/or the Controlled Substances Import and Export Act 
(84 Stat. 1285; 21 U.S.C. 951).
    (b) The term anabolic steroid means any drug or hormonal substance, 
chemically and pharmacologically related to testosterone (other than 
estrogens, progestins, and corticosteroids) that promotes muscle growth, 
and includes:
    (1) Boldenone;
    (2) Chlorotestosterone (4-chlortestosterone);
    (3) Clostebol;
    (4) Dehydrochlormethyltestosterone;
    (5) Dihydrotestosterone (4-dihydrotestosterone);
    (6) Drostanolone;
    (7) Ethylestrenol;
    (8) Fluoxymesterone;
    (9) Formebulone (formebolone);
    (10) Mesterolone;
    (11) Methandienone;
    (12) Methandranone;
    (13) Methandriol;
    (14) Methandrostenolone;
    (15) Methenolone;
    (16) Methyltestosterone;
    (17) Mibolerone;
    (18) Nandrolone;
    (19) Norethandrolone;
    (20) Oxandrolone;
    (21) Oxymesterone;
    (22) Oxymetholone;
    (23) Stanolone;
    (24) Stanozolol;
    (25) Testolactone;
    (26) Testosterone;
    (27) Trenbolone; and
    (28) Any salt, ester, or isomer of a drug or substance described or 
listed in this paragraph, if that salt, ester, or isomer promotes muscle 
growth. Except such term does not include an anabolic steroid which is 
expressly intended for administration through implants to cattle or 
other nonhuman species and which has been approved by the Secretary of 
Health and Human Services for such administration. If any person 
prescribes, dispenses, or distributes such steroid for human use, such 
person shall be considered to have prescribed, dispensed, or distributed 
an anabolic steroid within the meaning of this paragraph.
    (c) The term hearing means any hearing held pursuant to this part 
for the issuance, amendment, or repeal of any rule issuable pursuant to 
section 201 of the Act.
    (d) The term isomer means the optical isomer, except as used in 
Sec. 1308.11(d) and Sec. 1308.12(b)(4). As used in Sec. 1308.11(d), the 
term isomer means the optical, positional, or geometric isomer. As used 
in Sec. 1308.12(b)(4), the term isomer means the optical or geometric 
isomer.
    (e) The term interested person means any person adversely affected 
or aggrieved by any rule or propored rule issuable pursuant to section 
201 of the Act.
    (f) The term narcotic drug means any of the following whether 
produced directly or indirectly by extraction from substances of 
vegetable origin or independently by means of chemical synthesis or by a 
combination of extraction and chemical synthesis:
    (1) Opium, opiates, derivatives of opium and opiates, including 
their isomers, esters, ethers, salts, and salts of isomers, esters, and 
ethers whenever the existence of such isomers, esters, ethers and salts 
is possible within the specific chemical designation. Such term does not 
include the isoquinoline alkaloids of opium.
    (2) Poppy straw and concentrate of poppy straw.
    (3) Coca leaves, except coco leaves and extracts of coca leaves from 
which cocaine, ecgonine and derivatives of ecgonine or their salts have 
been removed.
    (4) Cocaine, its salts, optical and geometric isomers, and salts of 
isomers.
    (5) Ecgonine, its derivatives, their salts, isomers and salts of 
isomers.
    (6) Any compotnd, mixture, or preparation which contains any 
quantity of any of the substances referred to in subparagraphs (1) 
through (5).

[[Page 84]]

    (g) The term proceeding means all actions taken for the issuance, 
amendment, or repeal of any rule issued pursuant to section 201 of the 
Act, commencing with the publication by the Administrator of the 
proposed rule, amended rule, or repeal in the Federal Register.
    (h) Any term not defined in this section shall have the definition 
set forth in section 102 and 1001 of the Act (21 U.S.C. 802 and 951) and 
Sec. 1301.02 of this chapter.

[38 FR 8254, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973, 
and amended at 51 FR 15317, Apr. 23, 1986; 56 FR 5754, Feb. 13, 1991]